In recent months it has proved to be clear that a single biomarker would not suffice for the diagnosis of acute kidney injury, instead, it has been elaborated that a consortium of peptides such as KIM-1, NGAL, IL18 and IGFB7, TIMP-2 will be indicative for injuries of the nephron. This evidence concerns the gene IL18 and acute kidney injury.